5
Dujohn Laboratories Ltd
507482 BSE
Dujohn Laboratories Ltd
Healthcare BSE: 507482 Pharmaceuticals & Biotechnology
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Growth Rate
Revenue Growth
-
Net Income Growth
-100.00% →
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-
Quarterly Results
| Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit & Loss
| Mar 2009 | Mar 2010 | TTM | |
|---|---|---|---|
| Sales | 0 | 0 | 0 |
| Expenses | 0.01 | 0.02 | 0 |
| Operating Profit | -0.01 | -0.02 | 0 |
| Other Income | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 |
| PBT | -0.01 | -0.02 | 0 |
| Tax % | 0% | 0% | — |
| Net Profit | -0.01 | -0.02 | 0 |
| Div. Payout % | 0% | 0% | — |
Balance Sheet
| Mar 2009 | Mar 2010 | |
|---|---|---|
| Equity Capital | 3.51 | 3.51 |
| Reserves | -4.3 | -4.32 |
| Borrowings | 4.15 | 4.16 |
| Other Liabilities | 2.24 | 2.24 |
| Total Liabilities | 5.6 | 5.59 |
| Fixed Assets | 3.02 | 3.02 |
| CWIP | 0 | 0 |
| Investments | 0.01 | 0.01 |
| Other Assets | 2.57 | 2.56 |
| Total Assets | 5.6 | 5.59 |
Cash Flow
| Mar 2009 | Mar 2010 | |
|---|---|---|
| Operating | 0 | 0 |
| Investing | 0 | 0 |
| Financing | 0 | 0 |
| Net Cash Flow | 0 | 0 |
| Free Cash Flow | 0 | 0 |
| CFO/OP | 0 | 0 |
Ratios
| Mar 2009 | Mar 2010 | |
|---|---|---|
| ROCE % | — | -0.6% |
Documents
1
Board Meeting Outcome for Board Metting Outcome For Submission Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025
14 Nov 2025 - Board approved 51% JV acquisition for Rs12.41Cr and proposed Rs16.56Cr Mahape godown purchase; Q2 results. 14 Nov 2025 - Board approved 51% JV acquisition for Rs12.41Cr and proposed Rs16.56Cr Mahape godown purchase; Q2 results.
3
SUBMISSION OF STATEMENT OF DEVIATION OR VARIATION IN UTILIZATION OF FUNDS RAISED THROUGH INITIAL PUBLIC OFFER (''''''''IPO")
14 Nov 2025 - IPO funds total 1,829.52 lakh; Rs 12.80 lakh overutilised in issue expenses, adjusted. 14 Nov 2025 - IPO funds total 1,829.52 lakh; Rs 12.80 lakh overutilised in issue expenses, adjusted.
4
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
12 Jan - Certificate under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 for the quarter Ended 31st December 2025 12 Jan - Certificate under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 for the quarter Ended 31st December 2025
5
Board Meeting Outcome for Outcome Of Board Meeting
30 Jan - Board approved acquiring 51% of Nascent Global Impex LLP; cash consideration to be finalized; completion within three months. 30 Jan - Board approved acquiring 51% of Nascent Global Impex LLP; cash consideration to be finalized; completion within three months.
Frequently Asked Questions about Dujohn Laboratories Ltd
Where is Dujohn Laboratories Ltd (507482) listed?
Dujohn Laboratories Ltd is listed on the Indian stock exchanges. It is listed on BSE: 507482. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Dujohn Laboratories Ltd belong to?
Dujohn Laboratories Ltd operates in the Healthcare sector within the Pharmaceuticals & Biotechnology industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
How can I research Dujohn Laboratories Ltd on Tapetide?
On Tapetide, you can view Dujohn Laboratories Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Face Value ₹ 10